September 15 2007
The biotechnology industry faces a major problem; too many genetically modified mice and too few comparative pathologists. National and international programs aimed at unraveling the mysteries of the genome will produce a flood of transgenic and knockout mice but not the resources for their characterization. Current plans do not include the resources necessary to phenotype the over-abundance of animals. Most alarming, comparative pathologists, an essential resource, are in increasingly short supply and in danger of extinction. Genetic Engineering and Biotechnology News editorial.